MedPage Today (10/12, Firth) reports “suicides jumped 29% among adolescents ages 15 to 19 during the pandemic compared with prior years, according to” a “new edition of America’s Health Rankings Health of Women and Children Report from the United Health Foundation” that “captures 121 health measures based on the most recently available public health data from 30 different sources.” In addition, the report “captured trends related to women’s health,” finding that “across the country, the share of women reporting ‘frequent mental distress’ rose from 17% in 2017-2018 to 19.4% in 2019-2020 – an increase of 14%, or more than 1.2 million women.”

Related Links:

— MedPage Today (requires login and subscription)

Reuters (10/12, Satija) reports that the FDA “said on Wednesday there was a shortage of Adderall [amphetamine and dextroamphetamine], a treatment for” patients with “attention deficit hyperactivity disorder, following intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd.” While “other manufacturers continue to produce amphetamine mixed salts, but there is not sufficient supply to continue to meet U.S. market demand through those producers, the U.S. health regulator said.”

ABC News (10/12, Pezenik, Salzman, Egan) reports that “Dr. ​​Anish Dube from the American Psychiatric Association told ABC News” that “while stopping Adderall is generally not life-threatening, rebound symptoms, including inattention, hyperactivity and impulsivity, may return and be distressing.”

Related Links:

— “U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays ” Bhanvi Satija, Reuters, October 12, 2022

Medscape (10/11, Haelle, Subscription Publication) reports, “Opioids are the most common cause of fatal poisonings in young children, and their contribution to children’s deaths has been increasing, according to research” that “found that the proportion of deaths in U.S. children linked to opioids has doubled since the mid-2000s.” The study identified “731 child poisoning deaths” between 2005 and 2018 and found that “most of the deaths (61%) occurred in the child’s home, and in even more cases (71%) the child was being supervised when the poisoning occurred, most often by a parent (58.5%).” The findings were presented at the 2022 AAP National Conference & Exhibition.

Related Links:

— Medscape (requires login and subscription)

Kaiser Health News (10/11, Bebinger) reports, “Hospitals typically employ all sorts of [healthcare professionals] who specialize in the heart, lungs, and kidneys.” However, “for patients with an addiction or a condition related to drug or alcohol use, few hospitals have a clinician – whether that be a physician, nurse, therapist, or social worker – who specializes in addiction medicine.” This “absence is striking at a time when overdose deaths in the U.S. have reached record highs, and research shows patients face an increased risk of fatal overdose in the days or weeks after being discharged from a hospital.”

Related Links:

— “Hospitals Have Been Slow to Bring On Addiction Specialists ” Martha Bebinger, Kaiser Health News, October 11, 2022

According to the New York Times (10/11, Pearson), on Oct. 11, the US Preventive Services Task Force (USPSTF) “recommended for the first time that primary care” physicians “screen all children ages eight to 18 for anxiety, new guidance that highlights the ongoing mental health crisis among American youth.” Additionally, the USPSTF “reaffirmed its position that all adolescents ages 12 to 18 should be screened for depression.” By “making its recommendations, the task force hopes to reduce the number of children whose mental health conditions go undetected and untreated.”

Reuters (10/11, Steenhuysen) reports the task force’s recommendations “come at a time of rising rates of diagnosed mental health disorders among American young people.” It recommended “using screening questionnaires to identify children at risk, noting that studies show that children with such conditions benefit from treatment that may include cognitive behavioral therapy or psychotherapy.” The USPSTF, however, “found insufficient evidence to recommend routine screening of asymptomatic children or adolescents for suicide risk.”

HealthDay (10/11) provides links to the evidence report for depression, the final recommendation statement for depression, the evidence report for anxiety, and the final recommendation statement for anxiety, all of which are published in JAMA.

NBC News (10/11, Edwards) also covers the story.

Related Links:

— “U.S. experts urge anxiety screening for children 8 and older “Julie Steenhuysen, Reuters, October 11, 2022